Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE
Author:
Kamal Gupta,Harsh Mehta,Hwasoon Kim,Amanda Stebbins,Lisa M. Wruck,Daniel Muñoz,Mark B. Effron,R. David Anderson,Carl J. Pepine,Sandeep K. Jain,Saket Girotra,Darren A. DeWalt,Jeff Whittle,Catherine P. Benziger,Peter Farrehi,Li Zhou,Kirk U. Knowlton et al.
Publication:
American Heart Journal
© 2023 Published by Elsevier Inc.